Quell Therapeutics

Quell Therapeutics, based in London, focuses on advanced cell therapies to treat various illnesses, positioning itself strongly in the biotech sector. Their cutting-edge cellular technology outperforms traditional treatments and basic cell therapy options, which often lack effectiveness and innovation. Using a B2B model, Quell targets enterprises in related sectors to advance their solutions. Support from investors like AlbionVC and Point72 Ventures adds credibility and financial backing. Quell's innovative approach offers a promising alternative to conventional pharmaceuticals for tackling complex health issues.